Home Investigator Content Ludwig Kappos, University Hospital Basel and Principal Investigator

Ludwig Kappos, University Hospital Basel and Principal Investigator

349
0

Professor Kappos was the Principal Investigator for the EXPAND study. The study showed oral siponimod is the first potential therapy to meaningfully delay disability profession in typical secondary progressive multiple sclerosis (MS) patients.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.